Breast Cancer Clinical Trials in High Point, NC

Breast Cancer Clinical Trials in High Point, NC

View the best 10 breast cancer medical studies in High Point, North Carolina. Access promising new therapies by applying to a High Point-based Breast Cancer clinical trial.

Trials in High Point, North Carolina

Here are the top 10 medical studies for breast cancer in High Point, North Carolina

Image of Carle Cancer Center in Urbana, United States.

Denosumab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing whether denosumab can prevent breast cancer in women with a BRCA1 gene mutation, which is linked to a higher risk of developing the disease.
Image of Research Site in Columbus, United States.

Camizestrant

Recruiting2 awardsPhase 3
This trial studies if a new drug can help improve outcomes for breast cancer patients with a high risk of recurrence. Treatment lasts 7 years.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Cardiac MRI

Recruiting1 award8 criteria
This trial is testing if chemotherapy for breast cancer patients affects the heart, ability to exercise, and fatigue compared to those without cancer.
Image of Research Site in Jonesboro, United States.

Durvalumab +2 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial tests the effectiveness and safety of new treatments for TNBC and hormone receptor-low/HER2-negative breast cancer.
Image of Wake Forest School of Medicine in Winston-Salem, United States.

Choice PRO vs Fixed PRO

Recruiting1 award11 criteria
This trial is testing if letting people choose which health questionnaire to fill out leads to more people filling it out and if they find it more acceptable.
Image of Research Site in Duarte, United States.

Capecitabine +3 More

Anti-metabolites

Recruiting2 awardsPhase 3
This trial is testing a new drug called Dato-DXd to see if it works better than current treatments for patients with a specific type of breast cancer that has come back or spread and cannot be treated with certain common therapies. The drug aims to target and kill cancer cells more effectively.
Image of Research Site in Farmington, United States.

Camizestrant

Selective Estrogen Receptor Degrader (SERD)

Recruiting2 awardsPhase 3
This trial is testing camizestrant, a drug that blocks estrogen, in patients with ER+/HER2- early breast cancer at medium to high risk of recurrence. The goal is to see if it works better than standard hormone treatments by stopping cancer cells from growing.
Image of University of Alabama at Birmingham in Birmingham, United States.

Sacituzumab Govitecan +2 More

Antibody-Drug Conjugate

Recruiting1 awardPhase 2
This trial is studying avelumab in combination with two other drugs to treat triple negative breast cancer.
Image of University of South Alabama - Mitchell Cancer Institute in Mobile, United States.

T-DM1 +1 More

Antibody Drug Conjugate

Recruiting1 awardPhase 3
This trial is being done to see if adding tucatinib to T-DM1 helps patients with HER2 positive breast carcinoma.
Image of Mayo Clinic in Phoenix, United States.

GEN1046

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug, GEN1046, to see if it is safe to use alone or with other drugs to treat cancer.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.